Elizabeth Barrett

2020

In 2020, Elizabeth Barrett earned a total compensation of $2.5M as Chief Executive Officer at UroGen Pharma Ltd., a 90% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$468,650
Option Awards$876,164
Salary$636,987
Stock Awards$441,150
Other$43,716
Total$2,466,667

Barrett received $876.2K in option awards, accounting for 36% of the total pay in 2020.

Barrett also received $468.7K in non-equity incentive plan, $637K in salary, $441.2K in stock awards and $43.7K in other compensation.

Rankings

In 2020, Elizabeth Barrett's compensation ranked 4,610th out of 13,090 executives tracked by ExecPay. In other words, Barrett earned more than 64.8% of executives.

ClassificationRankingPercentile
All
4,610
out of 13,090
65th
Division
Manufacturing
1,873
out of 5,618
67th
Major group
Chemicals And Allied Products
730
out of 2,251
68th
Industry group
Drugs
625
out of 1,951
68th
Industry
Pharmaceutical Preparations
472
out of 1,456
68th

Pay ratio

Elizabeth Barrett's Pay$2,466,667
Median Employee's Pay$222,109
Pay Ratio

11

to 1

In 2020, the annual total compensation of Elizabeth Barrett was $2,466,667.

The annual total compensation of the median employee at UroGen Pharma Ltd. was $222,109.

The ratio of Elizabeth Barrett's pay to the pay of median employee was therefore 11 to one.

Source: SEC filing on April 28, 2021.

Barrett's colleagues

We found five more compensation records of executives who worked with Elizabeth Barrett at UroGen Pharma Ltd. in 2020.

2020

Jason Smith

UroGen Pharma Ltd.

General Counsel

2020

Molly Henderson

UroGen Pharma Ltd.

Chief Financial Officer

2020

Peter Pfreundschuh

UroGen Pharma Ltd.

Chief Financial Officer

2020

Mark Schoenberg

UroGen Pharma Ltd.

Chief Medical Officer

2020

Stephen Mullennix

UroGen Pharma Ltd.

Chief Operating Officer

News

You may also like